Dorsomorphin Dihydrochloride Market

Global Dorsomorphin Dihydrochloride Market Size, Share & Trends Analysis Report, By Product Type (Low Purity (Below 97%), Purity (Above 97%, and Below 99%), High Purity (Above 99%), and Others), By Application (Medical Treatment, Bioscience Research, and Others), Forecast (2021-2027)

Published: Oct 2021 | Report Code: OMR2024369 | Category : Pharmaceuticals | Delivery Format: /

The global dorsomorphin dihydrochloride market is anticipated to grow at a significant CAGR during the forecast period. Dorsomorphin dihydrochloride (BML-275 dihydrochloride; Compound C dihydrochloride) is an AMPK inhibitor with a Ki of 109 nM that is potent, selective, and ATP-competitive. Dorsomorphin dihydrochloride inhibits the BMP pathway by binding to the ALK2, ALK3, and ALK6 type receptors. Autophagy is induced by dorsomorphin dihydrochloride. In vitro, it stimulates cardiomyogenesis in mouse embryonic stem cells (ESCs) as part of a chemical cocktail to promote the neuronal development of hPSCs. In cancer cell lines, it has been shown to trigger autophagy through a mechanism unrelated to AMPK inhibition.

The growing need for bioscience research is propelling the global dorsomorphin dihydrochloride market. In addition, over the next six years, the hydrochloric (HCL) acid market is predicted to be driven by rising hydrogen chloride (HCI) use in the steel and pharmaceutical industries. However, market growth is expected to be hampered by a lack of raw material availability and resulting in price variations. Furthermore, over the projected period, government laws governing chlorofluorocarbon (CFC) emissions during HCl synthesis are expected to act as a market restraint. Increased investment in the oil and gas sector, as well as the mining industry, has led to market participants conducting R&D for application development, resulting in offering an opportunity for the global dorsomorphin dihydrochloride market.

Market Coverage

  •  The market number available for – 2020-2027
  •  The base year – 2020 
  • The forecast period is from 2021 to 2027
  • Segment Covered- 

o By  Product Type

o By Application

  • Competitive Landscape: R and D Systems, Abcam plc, Stemgent, Cayman Chemical, and others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Market Segmentation

Global Dorsomorphin Dihydrochloride Market, By Product Type

  • Low Purity (Below 97%)
  • Purity (Above 97% and Below 99%)
  • High Purity (Above 99%)
  • Others

Global Dorsomorphin Dihydrochloride Market, By Application

  • Medical Treatment
  • Bioscience Research
  •  Others

Global Dorsomorphin Dihydrochloride Market, By Geographic Region 

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World